We are live on ! Find out more
PGEN icon

Precigen

154 hedge funds and large institutions have $1.98B invested in Precigen in 2017 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 49 increasing their positions, 77 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.34% less ownership

Funds ownership: 84.71%84.37% (-0.34%)

10% less funds holding

Funds holding: 171154 (-17)

18% less capital invested

Capital invested by funds: $2.42B → $1.98B (-$434M)

22% less call options, than puts

Call options by funds: $15.3M | Put options by funds: $19.6M

27% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 37

36% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 77

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
154
Holders Change
-17
Holders Change %
-9.94%
% of All Funds
3.83%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
27
Increased
49
Reduced
77
Closed
37
Calls
$15.3M
Puts
$19.6M
Net Calls
-$4.35M
Net Calls Change
-$5.41M

PGEN Hedge Fund Activity: Q1 2017 in Review

154 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q1 2017, worth a combined $1.98B — down 18% from $2.42B a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of PGEN and 27 opened new positions — a net loss of 10 holders — while 77 trimmed existing stakes and 49 added.

The largest buyer was BlackRock, adding an estimated $52M. The largest seller was Fidelity Investments, cutting an estimated $11.9M.

  • 154 institutional investors held Precigen (PGEN) as of Q1 2017, down from 171 in Q4 2016.
  • Funds reported $1.98B of Precigen stock for Q1 2017, down 18% quarter-over-quarter.
  • 27 funds opened new Precigen positions in Q1 2017 and 37 closed out, a net change of -10 holders.
  • The largest Precigen buyer in Q1 2017 was BlackRock, an estimated $52M added.
  • The largest Precigen seller in Q1 2017 was Fidelity Investments, an estimated $11.9M sold.

Based on aggregated 13F filings for Q1 2017.